Category: Regulatory/FDA

FDA-News (1)

OPDP Warning Letter Cites CEO’s COVID Claims in Video for IND

Robert-Califf-FDA.news

Califf Is Confirmed as FDA Commissioner

Robert-Califf-FDA.news

Califf Confirmation in Jeopardy?

Nancy Myers.NEWS

Myers: FDA Priorities Persist Amid Challenges

CHC_general1

Omicron Causes FDA Suspension of Most U.S. Inspections Through Jan. 19

FDA-News (2)

CDER, CBER Approve Total of 60 New Products in 2021, Despite Challenges

CDER.News

CDER Steps in to Issue Warning Letters for Vaping Products Deemed Drugs

FDA-News (2)

FDA Reportedly Preparing Guidelines for Omicron-targeted Vaccine Studies

FDA-News (2)

OPDP Experimental Study to Examine Targeted Mechanism of Action Claims